Vaccine Excipient & Media Summary - Pink Book Appendiix B
Transcript of Vaccine Excipient & Media Summary - Pink Book Appendiix B
![Page 1: Vaccine Excipient & Media Summary - Pink Book Appendiix B](https://reader036.fdocuments.in/reader036/viewer/2022071601/613d4cbc736caf36b75bb079/html5/thumbnails/1.jpg)
B-7
![Page 2: Vaccine Excipient & Media Summary - Pink Book Appendiix B](https://reader036.fdocuments.in/reader036/viewer/2022071601/613d4cbc736caf36b75bb079/html5/thumbnails/2.jpg)
B-8
![Page 3: Vaccine Excipient & Media Summary - Pink Book Appendiix B](https://reader036.fdocuments.in/reader036/viewer/2022071601/613d4cbc736caf36b75bb079/html5/thumbnails/3.jpg)
B-9
![Page 4: Vaccine Excipient & Media Summary - Pink Book Appendiix B](https://reader036.fdocuments.in/reader036/viewer/2022071601/613d4cbc736caf36b75bb079/html5/thumbnails/4.jpg)
B-10
![Page 5: Vaccine Excipient & Media Summary - Pink Book Appendiix B](https://reader036.fdocuments.in/reader036/viewer/2022071601/613d4cbc736caf36b75bb079/html5/thumbnails/5.jpg)
B-11
![Page 6: Vaccine Excipient & Media Summary - Pink Book Appendiix B](https://reader036.fdocuments.in/reader036/viewer/2022071601/613d4cbc736caf36b75bb079/html5/thumbnails/6.jpg)
B-12
![Page 7: Vaccine Excipient & Media Summary - Pink Book Appendiix B](https://reader036.fdocuments.in/reader036/viewer/2022071601/613d4cbc736caf36b75bb079/html5/thumbnails/7.jpg)
Vaccine Excipient & Media Summary
References: Canadian National Advisory Committee on Immunization. Statement on thimero al. CM Comm Dis Rep. 2003 ;29(ACS-l): 1-10.
CDC. Thimerosal in vaccines: ajoint statement of the American Academy of Pediatrics and the Public Health Service. MMWR. 1999;48:563-565.
Fletcher MA. Hessel L. Plotkin SA. Human diploid cell strains (HDCS) viral vaccines. Dev Bioi Stolid. 1998;93:97-107.
Graben tein JD. Immunologic necessities: Diluents. adjuvant.s, and excipients. Hosp Pham,. 1996;31: 1387-92, 1397-140 l.
Graben tein JD. Clinical management of hypersensitivities to vaccine componenLS. Hasp Phon/'. 1997;32:77-84.87.
Hayftick L. The limited in vitro lifetime of human diploid cell strains. up Cell Res. 1965;37:614-636.
Jacob JP, Jones CM. Bailie JP. Characteristics of a human diploid cell designated MRC-5. Na/ure. 1970;227(5254): 168-170.
Jacobs JP. The status of human diploid cell strain MRC-5 as an approved subslTate for the production of viral vaccines. J Bioi Stalld. 1976;4(2):97-99.
Offit PA. Jew RK. Addressing parents's concerns: Do vaccines contain harmful preservative. adjuvants. additives. or residuals. Pediatrics. 2003; 112: 1394-140 I.
Grabenstein JD, (ed). immunoFacfs" 2011 Vaccines and immunologic Drugs. Wolters Kluwer Health, 2010.
This document can be found on the CDC website at: http://www.cdc.govlvaccinesJpubslpinkbookJdownloads/appendices/B/excipient-table-1.pdf 8-13